Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score
View Full Paper
Ask AI
Bookmark
Share
Discussion
Loading...
Member takes
Implication
Key Points
Key points are not available for this paper at this time.